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The symposium on spinal cord transplantation
has been shadowed, this year, by the loss of Dr.
Michael Goldberger (Medical College of
Pennsylvania, Philadelphia, USA) who passed
away in January 1992. Michael Goldberger’s
contribution to the field of spinal cord plasticity
and restoration, including transplantation, has been
enormous. His impact on the field is best
exemplified by the fact that all speakers in this
symposium had, at one point or another,
collaborated with him. It was therefore decided that
this symposium would be dedicated to his memory.
Five speakers presented their latest data in the
symposium. Four of them dealt with various
aspects of transplantation after mechanical lesions
of spinal cord neuronal populations and pathways
while the last speaker considered the potential for
therapeutic transplantation in motoneuronal
diseases.
Dr. Barbara Bregman (Georgetown University,
Washington, D.C., USA) presented a summary of
her work devoted to the comparative analysis of
plastic phenomena in the developing and adult
spinal cord/1/. After spinal cord lesions at birth,
fetal CNS transplants are able to support the
regeneration of all spinal projections. In the long
term, specific connections between regrowing
afferents and appropriate grafted targets are
required for maintenance of projections when
fibers originate from supraspinal structures,
whereas a similar specificity is not required when
fibers originate from the dorsal root ganglia.
Projections from the dorsal root ganglia can be
maintained even by non-target tissue transplants.
Behavioral experiments indicate that the regrowth
of severed afferents from supraspinal structures
allows some recovery of motor function at this
stage. Some plasticity of afferent systems in the
adult is observed, but to a much lesser extent as
concerns supraspinal fibers. Altogether, these data
point to the fact that different sets of afferents
display varying degrees of plasticity, and that
responses are largely, but not entirely, dependent
upon the stage of maturation.
Dr. Alan Tessler and colleagues (Medical
College of Pennsylvania, Philadelphia, USA)
analyzed another aspect of the same model by
looking at the prevention of retrograde cell death
after axotomy that can be provided by transplants
/8/. They showed two different phenomena. The
first is a regeneration of severed fibers comparable
to that described by Dr. Bregman. This
phenomenon, studied using both anatomical and
electrophysiological techniques, can be best
observed after rhizotomy, when transplants can
allow calcitonin gene-related peptide (CGRP)
fibers to regrow. The second phenomenon is a
rescue of axotomized neurons that do not send
axons to their appropriate targets, but survive due
to the presence of the transplant. This was shown
by comparing the effect of an axotomy at the T8
level, with or without a concurrent transplant, on
the survival of Clarke’s nucleus neurons at L1.
Normally, 30 to 40% of these neurons die after
axotomy, while different types of transplants
(spinal, cerebellar or cortical) provide the neurons
with enough survival factors for them to survive for
several months after the lesion. By examining the
relevant literature, the authors concluded
neurotrophin 3 (NT3) was enriched in all three
tissues that provided efficient transplants. In order
to determine the possible role of this factor in the
neuronal survival, the authors used another tissue,
the kidney, which contains high levels of NT3 but
is not of neural origin. They thus demonstrated that
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rescue of Clarke’s neurons from retrograde
neuronal death depends upon NT3.
Last in this series, Dr. Dena Howland (from
Michael Goldberger’s group at the Medical College
of Pennsylvania, Philadelphia, USA) presented her
results concerning behavioural recovery produced
by spinal transplants in newborn kittens with spinal
cord transection/4/. After transection, quadrupedal
locomotion is normally lost in kittens and never
recovers. When the transected area is filled with
fetal spinal cord tissue, allowing anatomical
connectivity to be reformed across the lesion site
using the transplant as a bridge, the development of
quadrupedal locomotor function, although not
normal, recovers significantly as compared to the
lesioned-only animals. In particular, animals with
transplants demonstrate weight-supported over-
ground locomotion and coordination between
forelimbs and hindlimbs.
Altogether, these three talks indicate that spinal
cord transection does not obligatorily lead to a
complete loss of function, and that the use of fetal
transplanted tissue to fill in the gap provides a
suitable substrate for the rescue of neurons, axonal
growth, and functional improvement. Grafts are
most effective when the lesions and grafts are
carried out during development.
Dr. Paul Reier (University of Florida,
Gainesville, USA) presented data on a different
model (contusion/compression damage) that
closely resembles spinal cord trauma encountered
clinically/6/. In this model, it should be noted that
not all long pathways are severed, and
preservation/recovery of function may depend upon
protection of these fibers from secondary injury.
Transplants of fetal spinal tissue, as a cell
suspension, into contusion injuries may provide
such a protective effect. Indeed, transplanted cells
colonized the contusion lesion and provided an
anatomical substrate for better preservation of
primary afferent and descending fiber systems.
Electrophysiological analysis of reflexes elicited at
levels below the lesion showed that, indeed,
transplants allowed a more normalized pattern of
reflex attenuation. Some locomotor improvement
was also recorded. This approach, based upon a
search for experimental models more closely
related to human injuries, provided some results
which, if extended to a longer period post-lesion
and replicated in larger animals, may eventually be
of clinical relevance.
The last talk was given by Dr. Marc Peschanski
(INSERM, Creteil, France) who presented a
summary of the work carried out by his group on
models of motoneuronal diseases in rats /5/. By
transplanting fetal spinal neurons as a cell
suspension, it is possible to obtain some anatomical
reconstruction of the spinal circuitry. Afferent
fibers respond differently to the loss of
postsynaptic target neurons and to the introduction
of transplanted cells, but maintenance of afferent
systems can still be observed---- at least in the most
peripheral portions of the transplants--- several
months after the lesion/transplant procedure.
Transplanted neurons are, however, unable to send
an axon out into the ventral root. Long axonal
extension out of the spinal cord can be obtained,
nevertheless, if a peripheral nerve guide is
provided. In a follow-up study, this group used a
"panning" technique that allows fractionation of
cell suspensions specifically enriched in
motoneurons. Using the low affinity nerve growth
factor receptor as a ligand, it is possible to enrich
the motoneuronal pool in transplants. These
motoneurons develop well after transplantation and
receive innervation from the host. Although the use
of transplants to replace motoneurons at all levels
of the spinal cord in motoneuronal diseases is not
foreseeable, the potential may exist eventually for
local replacement of a subset of motoneurons,
allowing for functional recovery of a specific
neuromuscular connection.
During the discussion, Drs. Sieradzan (London,
U.K.), Horvat (Paris, France) and Bunge (Miami,
FL, USA) presented their results concerning
various types of transplants into the spinal cord
/2,3,7/, exemplifying further the breadth of interest
in this topic. The entire session concerned
experimental work, and it is clear to everyone that
spinal cord transplantation has not reached the
point for clinical attempts. Clinical indications and
even potentials cannot yet be clearly defined. The
talks and discussion demonstrated, however, that
this far-fetched goal is not entirely out of reach,
and that both anatomical and functional recovery
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can be observed in specific experimental
conditions.
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